Long-term Assessment of Chlormethine Gel in Mycosis Fungoides
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorFondazione Italiana Linfomi - ETS
About this trial
The study aims to provide comprehensive insights into the long-term therapeutic outcomes, potential adverse effects, and overall patient experience with chlormethine gel, thereby informing clinical practice and guiding future treatment strategies for mycosis fungoides.
Eligibility criteria
Qualifiers
Patients age ≥ 18
Histologically confirmed diagnosis of MF based on WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition
Patients who are capable of understanding and willing, and able to read and write in Italian
Patients who have signed informed consent form
Disqualifiers
Patients for whom retrospective data or information on the type of therapy, duration, and clinical outcomes are not available in the center's medical records.
Refuse to sign a written informed consent.
Patients not meeting the above-mentioned inclusion criteria
Trial design
Treatments tested in this trial
- Not listed
Trial groups
190 Participants
are grouped into 1 trial groupSponsors and collaborators
Fondazione Italiana Linfomi - ETS
Lead sponsor
RECORDATI GROUP
Collaborator
Source ClinicalTrials.gov